The Guardian reported on 4 April 2026 that the MHRA had opened investigations into UK clinics making therapeutic claims about unregulated peptide products
Frequently Asked Questions About Healthletic BPC-157 What exactly is BPC-157 and where does it come from
In October 2025, the Welsh government confirmed plans to develop a new clinical pathway to treat obesity as a chronic, recurring condition and support equitable access to weight-loss drugs and wrap-around care, including in appropriate primary care and community settings 42
Whilst RCTs have reported DKA ranging from 0.84.3% [34], real-world rates of DKA have ranged from 0.0 [38]3.5% [25] with one outlier of 12.5% [14]
And, it remains unclear how changes to contemporary red meat consumption patterns may serve as an applicable intervention to prevent and decrease HTN and related complications
These metabolites have been found to target specific receptors among the repertoire expressed by the EECs, triggering a hormonal response
